KLR
Kailera Therapeutics
KLRA • XNAS • Stock Fundamentals
Kailera Therapeutics is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Ronald C. Renaud Jr., with a market cap of $2.8B.
Market Cap$2.8B
CEORonald C. Renaud Jr.
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 26, 2026 · 2 days agoQ2 2026
View reportNext EarningsAug 7, 2026 · in 2 monthsQ3 2026
Financials
Based on Q2 2026 filing
D/E-2.42%
Current Ratio9.67
Total Debt$10.5M
Cash$111.8M
KLR
Kailera Therapeutics FAQ
Common questions about Kailera Therapeutics
Kailera Therapeutics (KLRA) has a market capitalization of $2.8B and trades on XNAS.